Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity
- PMID: 1404600
- PMCID: PMC240142
- DOI: 10.1128/JVI.66.11.6496-6501.1992
Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity
Abstract
The Epstein-Barr virus latent membrane protein (LMP) is an integral membrane protein that is expressed in cells latently infected with the virus. LMP is believed to play an important role in Epstein-Barr virus transformation and has been shown to induce expression of several cellular proteins. We performed a series of experiments that demonstrated that LMP is an efficient transactivator of expression from the human immunodeficiency virus type 1 long terminal repeat (HIV-1 LTR). Mutation or deletion of the NF-kappa B elements in the LTR abolished the transactivation, indicating that the LMP effect on HIV expression was due to induction of NF-kappa B activity. Experiments in which the HIV-1 Tat protein was coexpressed in cells together with LMP showed that Tat was able to potentiate the transactivation. Surprisingly, a synergistic effect of the two proteins was observed even in the absence of the recognized target region for Tat (TAR) in the HIV-1 LTR.
Similar articles
-
Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993. J Virol. 1993. PMID: 8386279 Free PMC article.
-
Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.J Virol. 1996 Sep;70(9):5777-85. doi: 10.1128/JVI.70.9.5777-5785.1996. J Virol. 1996. PMID: 8709193 Free PMC article.
-
Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.Virology. 1997 Aug 18;235(1):48-64. doi: 10.1006/viro.1997.8672. Virology. 1997. PMID: 9300036
-
TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.AIDS. 1997 Mar;11(3):297-303. doi: 10.1097/00002030-199703110-00006. AIDS. 1997. PMID: 9147420
-
Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review.Adv Neuroimmunol. 1994;4(3):291-303. doi: 10.1016/s0960-5428(06)80270-6. Adv Neuroimmunol. 1994. PMID: 7874398 Review.
Cited by
-
Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeats.J Virol. 2010 Mar;84(5):2236-44. doi: 10.1128/JVI.01972-09. Epub 2009 Dec 16. J Virol. 2010. PMID: 20015988 Free PMC article.
-
Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.Oncogene. 2009 May 21;28(20):2100-11. doi: 10.1038/onc.2009.74. Epub 2009 Apr 20. Oncogene. 2009. PMID: 19377508 Free PMC article.
-
Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway.J Virol. 1996 Jan;70(1):641-6. doi: 10.1128/JVI.70.1.641-646.1996. J Virol. 1996. PMID: 8523586 Free PMC article.
-
Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.J Virol. 2001 Oct;75(19):9129-41. doi: 10.1128/JVI.75.19.9129-9141.2001. J Virol. 2001. PMID: 11533177 Free PMC article.
-
Simian homologues of Epstein-Barr virus.Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29;356(1408):489-97. doi: 10.1098/rstb.2000.0776. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11313007 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources